Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Principia Biopharma reports discovery of FGFR inhibitors

Nov. 25, 2014

Sanofi develops novel CD38 inhibitors

Nov. 25, 2014

Max-Planck-Gesellschaft and BTI divulge natural PPAR modulators

Nov. 25, 2014

Galapagos patents novel CFTR activators

Nov. 24, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

New GABA(A) receptor agonists disclosed by Sichuan Haisco

Nov. 24, 2014

Nimbus Apollo reports new ACC2 inhibitors

Nov. 24, 2014

Karus Therapeutics patents novel HDAC6 inhibitors

Nov. 24, 2014

Merz Pharma patents new 5-HT1A and 5-HT1B agonists

Nov. 21, 2014

Arena Pharmaceuticals reports development of Mas receptor modulators

Nov. 21, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...